Clinical Trials Directory

Trials / Completed

CompletedNCT03967171

The Comparison of the Effect of Different Oxytocin Administrations on the Blood Loss During Cesarean Delivery

The Comparison of the Effect of Different Oxytocin Administrations on the Blood Loss During Cesarean Delivery: a Randomised Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
Bezmialem Vakif University · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study compares the effect of starting intravenous oxytocin infusion early before uterine incision versus late after umbilical cord clamping on the blood loss during elective cesarean section

Detailed description

Postpartum hemorrhage (PPH) is still the major cause of maternal morbidity and mortality worldwide contributing to nearly 25% of direct maternal deaths. The average blood loss during cesarean section is 1000 ml which is nearly double the blood loss during vaginal delivery. Worldwide, the most commonly used uterotonic for the prevention of PPH is oxytocin. Several regimens of oxytocin have been tested during cesarean section with variable wanted (uterotonic) and unwanted (cardiovascular) effects. In the current study, we tested the hypothesis that initiating IV oxytocin infusion earlier before uterine incision would induce a rapid acceptable uterine contraction and minimize the intraoperative blood loss than the same dose administered after delivery of the fetus.

Conditions

Interventions

TypeNameDescription
OTHERbefore uterine incision oxytocinblood loss during elective cesarean section
OTHERafter clamping the umbilical cord oxytocinblood loss during elective cesarean section

Timeline

Start date
2019-05-01
Primary completion
2019-06-20
Completion
2019-07-01
First posted
2019-05-30
Last updated
2019-09-24

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03967171. Inclusion in this directory is not an endorsement.